← Back to headlines
Novo Nordisk Aims to Expand Access to Weight-Loss Drugs in Japan
Pharmaceutical company Novo Nordisk is planning to broaden the availability of its weight-loss medications within the Japanese market.
19 Mar, 08:48 — 19 Mar, 08:48
Sources
Showing 1 of 1 sources
